Kiyohiro Ando

3.9k total citations
59 papers, 3.1k citations indexed

About

Kiyohiro Ando is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Kiyohiro Ando has authored 59 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 22 papers in Oncology and 14 papers in Genetics. Recurrent topics in Kiyohiro Ando's work include Neuroblastoma Research and Treatments (12 papers), Cancer-related Molecular Pathways (10 papers) and Cell death mechanisms and regulation (8 papers). Kiyohiro Ando is often cited by papers focused on Neuroblastoma Research and Treatments (12 papers), Cancer-related Molecular Pathways (10 papers) and Cell death mechanisms and regulation (8 papers). Kiyohiro Ando collaborates with scholars based in Japan, United States and Germany. Kiyohiro Ando's co-authors include Francis V. Chisari, Luca G. Guidotti, Robert D. Schreiber, Akira Nakagawara, Tetsuya Ishikawa, Takashi Moriyama, Toshinori Ozaki, S Wirth, H J Schlicht and S N Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Kiyohiro Ando

57 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiyohiro Ando Japan 25 1.2k 1.1k 867 725 664 59 3.1k
Giacomo Paonessa Italy 29 1.6k 1.4× 582 0.5× 722 0.8× 567 0.8× 794 1.2× 54 3.6k
Masaaki Shiina Japan 31 1.9k 1.6× 564 0.5× 496 0.6× 475 0.7× 282 0.4× 85 3.2k
Jason S. Simon United States 23 978 0.8× 2.0k 1.8× 698 0.8× 2.2k 3.1× 796 1.2× 59 4.8k
Massimiliano Pagani Italy 32 2.0k 1.6× 695 0.6× 1.5k 1.8× 120 0.2× 551 0.8× 62 4.2k
Hidehiro Fukuyama Japan 29 2.3k 1.9× 456 0.4× 2.5k 2.9× 140 0.2× 613 0.9× 46 4.9k
Doris Coit United States 19 958 0.8× 1.3k 1.2× 507 0.6× 1.6k 2.2× 231 0.3× 23 3.3k
Rafael Aldabe Spain 24 785 0.7× 487 0.4× 309 0.4× 443 0.6× 246 0.4× 56 1.8k
M. Inmaculada Barrasa United States 27 2.5k 2.1× 461 0.4× 323 0.4× 169 0.2× 233 0.4× 45 3.7k
Olivier Donzé Switzerland 25 2.3k 1.9× 289 0.3× 979 1.1× 120 0.2× 308 0.5× 35 3.5k
Atsuo Ochi Canada 29 895 0.7× 328 0.3× 2.0k 2.3× 116 0.2× 570 0.9× 53 3.1k

Countries citing papers authored by Kiyohiro Ando

Since Specialization
Citations

This map shows the geographic impact of Kiyohiro Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyohiro Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyohiro Ando more than expected).

Fields of papers citing papers by Kiyohiro Ando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiyohiro Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyohiro Ando. The network helps show where Kiyohiro Ando may publish in the future.

Co-authorship network of co-authors of Kiyohiro Ando

This figure shows the co-authorship network connecting the top 25 collaborators of Kiyohiro Ando. A scholar is included among the top collaborators of Kiyohiro Ando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyohiro Ando. Kiyohiro Ando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ando, Kiyohiro, Noriko Motoi, Toshihiko Iizuka, et al.. (2024). STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-γ-induced Apoptosis in Urothelial Cancer. Anticancer Research. 44(5). 1925–1930. 1 indexed citations
2.
Ando, Kiyohiro, Noriko Motoi, Toshihiko Iizuka, et al.. (2023). Positive regulatory loop of platelet-derived growth factor DD-induced STAT3 activation is associated with poor prognosis in advanced urothelial carcinoma. Biochemical and Biophysical Research Communications. 676. 165–170. 1 indexed citations
3.
Akter, Jesmin, Hisanori Takenobu, Masayuki Haruta, et al.. (2023). ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors. BMC Cancer. 23(1). 313–313. 8 indexed citations
4.
Ando, Kiyohiro, Masaharu Inoue, Hisanori Takenobu, et al.. (2022). Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma. Anticancer Research. 42(2). 1131–1136. 15 indexed citations
5.
Ando, Kiyohiro, Yuanyuan Li, Renuka Raman, et al.. (2021). FANCI functions as a repair/apoptosis switch in response to DNA crosslinks. Developmental Cell. 56(15). 2207–2222.e7. 11 indexed citations
6.
Ando, Kiyohiro, Yohko Nakamura, Hiroki Nagase, et al.. (2019). Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells. International Journal of Molecular Sciences. 20(15). 3700–3700. 17 indexed citations
7.
Suenaga, Yusuke, Mami Yamamoto, Tetsushi Sakuma, et al.. (2019). TAp63 represses transcription of MYCN/NCYM gene and its high levels of expression are associated with favorable outcome in neuroblastoma. Biochemical and Biophysical Research Communications. 518(2). 311–318. 9 indexed citations
8.
Ando, Kiyohiro, Melissa J. Parsons, Brittany A. Rohrman, et al.. (2017). NPM1 directs PIDDosome-dependent caspase-2 activation in the nucleolus. The Journal of Cell Biology. 216(6). 1795–1810. 51 indexed citations
9.
Ando, Kiyohiro, Toshinori Ozaki, Toru Hirota, & Akira Nakagawara. (2013). NFBD1/MDC1 Is Phosphorylated by PLK1 and Controls G2/M Transition through the Regulation of a TOPOIIα-Mediated Decatenation Checkpoint. PLoS ONE. 8(12). e82744–e82744. 9 indexed citations
10.
Komatsu, Shugo, Hisanori Takenobu, Toshinori Ozaki, et al.. (2009). Plk1 regulates liver tumor cell death by phosphorylation of TAp63. Oncogene. 28(41). 3631–3641. 24 indexed citations
11.
Okoshi, Rintaro, Kiyohiro Ando, Yusuke Suenaga, et al.. (2009). Transcriptional regulation of tumor suppressor p53 by cAMP‐responsive element‐binding protein/AMP‐activated protein kinase complex in response to glucose deprivation. Genes to Cells. 14(12). 1429–1440. 22 indexed citations
12.
Sang, Meixiang, Kiyohiro Ando, Rintaro Okoshi, et al.. (2009). Plk3 inhibits pro‐apoptotic activity of p73 through physical interaction and phosphorylation. Genes to Cells. 14(7). 775–788. 16 indexed citations
13.
Ozaki, Toshinori, Hideki Yamamoto, Sayaka Ono, et al.. (2008). Inhibitory Role of Plk1 in the Regulation of p73-dependent Apoptosis through Physical Interaction and Phosphorylation. Journal of Biological Chemistry. 283(13). 8555–8563. 47 indexed citations
14.
Okoshi, Rintaro, Toshinori Ozaki, Hideki Yamamoto, et al.. (2007). Activation of AMP-activated Protein Kinase Induces p53-dependent Apoptotic Cell Death in Response to Energetic Stress. Journal of Biological Chemistry. 283(7). 3979–3987. 237 indexed citations
15.
Sang, Meixiang, Yuanyuan Li, Toshinori Ozaki, et al.. (2006). p73-dependent induction of 14-3-3σ increases the chemo-sensitivity of drug-resistant human breast cancers. Biochemical and Biophysical Research Communications. 347(1). 327–333. 17 indexed citations
16.
Ando, Kiyohiro, Kazumasa Hiroishi, Takehisa Kaneko, et al.. (1997). Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. The Journal of Immunology. 158(11). 5283–5291. 222 indexed citations
17.
Chemin, Isabelle, S Takahashi, Claire Belloc, et al.. (1996). Differential Induction of Carcinogen Metabolizing Enzymes in A Transgenic Mouse Model of Fulminant Hepatitis. Hepatology. 24(3). 649–656. 26 indexed citations
18.
Ando, Kiyohiro, Hitoshi Funahashi, Nobuo Kato, & Hitoshi Takagi. (1995). Effectiveness of iodine in suppressing tumor cell proliferation in cultivated MCF-7 human breast cancer cells. 30(4). 628–635. 1 indexed citations
19.
Ando, Kiyohiro, Luca G. Guidotti, Anna Cerny, Tetsuya Ishikawa, & Francis V. Chisari. (1994). CTL access to tissue antigen is restricted in vivo.. The Journal of Immunology. 153(2). 482–488. 104 indexed citations
20.
Ando, Kiyohiro, Takashi Moriyama, Luca G. Guidotti, et al.. (1993). Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.. The Journal of Experimental Medicine. 178(5). 1541–1554. 384 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026